"Zoetis Stock Plummets Amid Reports of Arthritis Shots Sickening Pets"
Zoetis stock plummeted after reports suggested that its arthritis shots for pets, Librela and Solensia, may have caused illness in dogs and cats. Despite gaining FDA approval, health regulators have received thousands of reports of side effects, leading to concerns about the drugs' safety. While Zoetis maintains that less than 1% of animals have experienced side effects, negative headlines could impact the uptake of the drugs. The company emphasizes the importance of pet owners consulting with veterinarians to weigh the risks and benefits before starting treatment.